Topics

Gilead’s Luisa Stamm Named Assembly Biosciences Chief Medical Officer

18:22 EST 7 Nov 2019 | Xconomy

Luisa Stamm has joined Assembly Biosciences (NASDAQ: ASMB) as chief medical officer. Stamm comes to South San Francisco-based Assembly from Gilead Siences (NASDAQ: GILD), where she was executive director in the liver diseases therapeutic area, as well as executive director in the HIV and emerging viruses therapeutic area. Assembly is developing drugs for hepatitis B […]

Original Article: Gilead’s Luisa Stamm Named Assembly Biosciences Chief Medical Officer

NEXT ARTICLE

More From BioPortfolio on "Gilead’s Luisa Stamm Named Assembly Biosciences Chief Medical Officer"

Quick Search

Relevant Topic

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...